TY  - GEN
AU  - Rudek,M A
AU  - Figg,W D
AU  - Dyer,V
AU  - Dahut,W
AU  - Turner,M L
AU  - Steinberg,S M
AU  - Liewehr,D J
AU  - Kohler,D R
AU  - Pluda,J M
AU  - Reed,E
TI  - Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer
SN  - 0732-183X
PY  - 2001///0329
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - pharmacokinetics
KW  - Endothelial Growth Factors
KW  - blood
KW  - Enzyme Inhibitors
KW  - Female
KW  - Fibroblast Growth Factor 2
KW  - Humans
KW  - Lymphokines
KW  - Male
KW  - Matrix Metalloproteinase 2
KW  - Matrix Metalloproteinase 9
KW  - Matrix Metalloproteinase Inhibitors
KW  - Matrix Metalloproteinases
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Statistics, Nonparametric
KW  - Tetracyclines
KW  - Vascular Endothelial Growth Factor A
KW  - Vascular Endothelial Growth Factors
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1200/JCO.2001.19.2.584
ER  -